The Antiviral Efficacy of HIV-Specific CD8 T-Cells to a Conserved Epitope Is Heavily Dependent on the Infecting HIV-1 Isolate

English version České info

A major challenge to developing a successful HIV vaccine is the vast diversity of viral sequences, yet it is generally assumed that an epitope conserved between different strains will be recognised by responding T-cells. We examined whether an invariant HLA-B8 restricted Nef_90–97 epitope FL8 shared between five high titre viruses and eight recombinant vaccinia viruses expressing Nef from different viral isolates (clades A–H) could activate antiviral activity in FL8-specific cytotoxic T-lymphocytes (CTL). Surprisingly, despite epitope conservation, we found that CTL antiviral efficacy is dependent on the infecting viral isolate. Only 23% of Nef proteins, expressed by HIV-1 isolates or as recombinant vaccinia-Nef, were optimally recognised by CTL. Recognition of the HIV-1 isolates by CTL was independent of clade-grouping but correlated with virus-specific polymorphisms in the epitope flanking region, which altered immunoproteasomal cleavage resulting in enhanced or impaired epitope generation. The finding that the majority of virus isolates failed to present this conserved epitope highlights the importance of viral variance in CTL epitope flanking regions on the efficiency of antigen processing, which has been considerably underestimated previously. This has important implications for future vaccine design strategies since efficient presentation of conserved viral epitopes is necessary to promote enhanced anti-viral immune responses.

Vyšlo v časopise: The Antiviral Efficacy of HIV-Specific CD8 T-Cells to a Conserved Epitope Is Heavily Dependent on the Infecting HIV-1 Isolate. PLoS Pathog 7(5): e32767. doi:10.1371/journal.ppat.1001341
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.ppat.1001341

Souhrn

Zdroje

1. McMichaelA

MwauM

HankeT

2002 HIV T cell vaccines, the importance of clades. Vaccine 20 1918 1921

2. GaschenB

TaylorJ

YusimK

FoleyB

GaoF

2002 Diversity considerations in HIV-1 vaccine selection. Science 296 2354 2360

3. WalkerB

KorberB

2001 Immune control of HIV: the obstacles of HLA and viral diversity. Nat Immunol 2 473 475

4. McMichaelA

Rowland-JonesS

2001 Cellular immune responses to HIV. Nature 410 980 987

5. McMichaelAJ

2006 HIV vaccines. Annu Rev Immunol 24 227 255

6. LetourneauS

ImEJ

MashishiT

BreretonC

BridgemanA

2007 Design and pre-clinical evaluation of a universal HIV-1 vaccine. PLoS One 2 e984

7. FinnefrockAC

LiuX

OpalkaDW

ShiverJW

CasimiroDR

2007 HIV type 1 vaccines for worldwide use: predicting in-clade and cross-clade breadth of immune responses. AIDS Res Hum Retroviruses 23 1283 1292

8. FrahmN

NickleDC

LindeCH

CohenDE

ZunigaR

2008 Increased detection of HIV-specific T cell responses by combination of central sequences with comparable immunogenicity. Aids 22 447 456

9. SantraS

KorberBT

MuldoonM

BarouchDH

NabelGJ

2008 A centralized gene-based HIV-1 vaccine elicits broad cross-clade cellular immune responses in rhesus monkeys. Proc Natl Acad Sci U S A 105 10489 10494

10. AllenTM

AltfeldM

2008 Crippling HIV one mutation at a time. J Exp Med 205 1003 1007

11. StreeckH

FrahmN

WalkerB

2009 The role of IFN-gamma Elispot assay in HIV vaccine research. Nat Protoc 4 461 469

12. AltfeldM

AddoMM

ShankarappaR

LeePK

AllenTM

2003 Enhanced detection of human immunodeficiency virus type 1-specific T-cell responses to highly variable regions by using peptides based on autologous virus sequences. J Virol 77 7330 7340

13. GoonetillekeN

LiuMK

Salazar-GonzalezJF

FerrariG

GiorgiE

2009 The first T cell response to transmitted/founder virus contributes to the control of acute viremia in HIV-1 infection. J Exp Med 206 1253 1272

14. LeeJK

Stewart-JonesG

DongT

HarlosK

Di GleriaK

2004 T cell cross-reactivity and conformational changes during TCR engagement. J Exp Med 200 1455 1466

15. MooreCB

JohnM

JamesIR

ChristiansenFT

WittCS

2002 Evidence of HIV-1 adaptation to HLA-restricted immune responses at a population level. Science 296 1439 1443

16. MatthewsPC

LeslieAJ

KatzourakisA

CrawfordH

PayneR

2009 HLA footprints on human immunodeficiency virus type 1 are associated with interclade polymorphisms and intraclade phylogenetic clustering. J Virol 83 4605 4615

17. BennettM

NgH

AliA

YangO

2008 Cross-clade detection of HIV-1-specific cytotoxic T lymphocytes does not reflect cross-clade antiviral activity. J Infect Dis 197 390 397

18. D'SouzaM

AltfeldM

2008 Measuring HIV-1-specific T cell immunity: how valid are current assays? J Infect Dis 197 337 339

19. Le GallS

StamegnaP

WalkerB

2007 Portable flanking sequences modulate CTL epitope processing. J Clin Invest 117 3563 3575

20. TenzerS

WeeE

BurgevinA

Stewart-JonesG

FriisL

2009 Antigen processing influences HIV-specific cytotoxic T lymphocyte immunodominance. Nat Immunol 10 6 636 46

21. ZimbwaP

MilicicA

FraterJ

ScribaT

WillisA

2007 Precise identification of a human immunodeficiency virus type 1 antigen processing mutant. J Virol 81 2031 2038

22. AllenT

AltfeldM

YuX

O'SullivanK

LichterfeldM

2004 Selection, transmission, and reversion of an antigen-processing cytotoxic T-lymphocyte escape mutation in human immunodeficiency virus type 1 infection. J Virol 78 7069 7078

23. DraenertR

Le GallS

PfafferottK

LeslieA

ChettyP

2004 Immune selection for altered antigen processing leads to cytotoxic T lymphocyte escape in chronic HIV-1 infection. J Exp Med 199 905 915

24. MilicicA

PriceD

ZimbwaP

BoothB

BrownH

2005 CD8+ T cell epitope-flanking mutations disrupt proteasomal processing of HIV-1 Nef. J Immunol 175 4618 4626

25. YokomakuY

MiuraH

TomiyamaH

Kawana-TachikawaA

TakiguchiM

2004 Impaired processing and presentation of cytotoxic-T-lymphocyte (CTL) epitopes are major escape mechanisms from CTL immune pressure in human immunodeficiency virus type 1 infection. J Virol 78 1324 1332

26. SeifertU

LiermannH

RacanelliV

HaleniusA

WieseM

2004 Hepatitis C virus mutation affects proteasomal epitope processing. J Clin Invest 114 250 259

27. KimuraY

GushimaT

RawaleS

KaumayaP

WalkerC

2005 Escape mutations alter proteasome processing of major histocompatibility complex class I-restricted epitopes in persistent hepatitis C virus infection. J Virol 79 4870 4876

28. KawashimaY

PfafferottK

FraterJ

MatthewsP

PayneR

2009 Adaptation of HIV-1 to human leukocyte antigen class I. Nature 458 641 645

29. LoffredoJT

BurwitzBJ

RakaszEG

SpencerSP

StephanyJJ

2007 The antiviral efficacy of simian immunodeficiency virus-specific CD8+ T cells is unrelated to epitope specificity and is abrogated by viral escape. J Virol 81 2624 2634

30. YangOO

KalamsSA

TrochaA

CaoH

LusterA

1997 Suppression of human immunodeficiency virus type 1 replication by CD8+ cells: evidence for HLA class I-restricted triggering of cytolytic and noncytolytic mechanisms. J Virol 71 3120 3128

31. CollinsKL

ChenBK

KalamsSA

WalkerBD

BaltimoreD

1998 HIV-1 Nef protein protects infected primary cells against killing by cytotoxic T lymphocytes. Nature 391 397 401

32. AliA

RealegenoS

YangOO

LewisMJ

2009 Simultaneous assessment of CD4 and MHC-I downregulation by Nef primary isolates in the context of infection. J Virol Methods 161 297 304

33. LewisMJ

BalamuruganA

OhnoA

KilpatrickS

NgHL

2008 Functional adaptation of Nef to the immune milieu of HIV-1 infection in vivo. J Immunol 180 4075 4081

34. KesslerB

GlasR

PloeghH

2002 MHC class I antigen processing regulated by cytosolic proteolysis-short cuts that alter peptide generation. Mol Immunol 39 171 179

35. SeifertU

MaranonC

ShmueliA

DesoutterJF

WesoloskiL

2003 An essential role for tripeptidyl peptidase in the generation of an MHC class I epitope. Nat Immunol 4 375 379

36. KloetzelP

2004 Generation of major histocompatibility complex class I antigens: functional interplay between proteasomes and TPPII. Nat Immunol 5 661 669

37. YewdellJ

ReitsE

NeefjesJ

2003 Making sense of mass destruction: quantitating MHC class I antigen presentation. Nat Rev Immunol 3 952 961

38. Lucchiari-HartzM

LindoV

HitzigerN

GaedickeS

SaveanuL

2003 Differential proteasomal processing of hydrophobic and hydrophilic protein regions: contribution to cytotoxic T lymphocyte epitope clustering in HIV-1-Nef. Proc Natl Acad Sci U S A 100 7755 7760

39. MoAX

van LelyveldSF

CraiuA

RockKL

2000 Sequences that flank subdominant and cryptic epitopes influence the proteolytic generation of MHC class I-presented peptides. J Immunol 164 4003 4010

40. CascioP

HiltonC

KisselevAF

RockKL

GoldbergAL

2001 26S proteasomes and immunoproteasomes produce mainly N-extended versions of an antigenic peptide. EMBO J 20 2357 2366

41. KesslerBM

GlasR

PloeghHL

2002 MHC class I antigen processing regulated by cytosolic proteolysis-short cuts that alter peptide generation. Mol Immunol 39 171 179

42. GaczynskaM

RockKL

SpiesT

GoldbergAL

1994 Peptidase activities of proteasomes are differentially regulated by the major histocompatibility complex-encoded genes for LMP2 and LMP7. Proc Natl Acad Sci U S A 91 9213 9217

43. AltfeldM

AllenT

YuX

JohnstonM

AgrawalD

2002 HIV-1 superinfection despite broad CD8+ T-cell responses containing replication of the primary virus. Nature 420 434 439

44. McElrathM

De RosaS

MoodieZ

DubeyS

KiersteadL

2008 HIV-1 vaccine-induced immunity in the test-of-concept Step Study: a case-cohort analysis. Lancet 372 1894 1905

45. AltfeldM

AllenTM

2006 Hitting HIV where it hurts: an alternative approach to HIV vaccine design. Trends Immunol 27 504 510

46. GoepfertPA

LummW

FarmerP

MatthewsP

PrendergastA

2008 Transmission of HIV-1 Gag immune escape mutations is associated with reduced viral load in linked recipients. J Exp Med 205 1009 1017

47. KiepielaP

NgumbelaK

ThobakgaleC

RamduthD

HoneyborneI

2007 CD8+ T-cell responses to different HIV proteins have discordant associations with viral load. Nat Med 13 46 53

48. LichterfeldM

YuX

Le GallS

AltfeldM

2005 Immunodominance of HIV-1-specific CD8(+) T-cell responses in acute HIV-1 infection: at the crossroads of viral and host genetics. Trends Immunol 26 166 171

49. AltfeldM

KalifeE

QiY

StreeckH

LichterfeldM

2006 HLA Alleles Associated with Delayed Progression to AIDS Contribute Strongly to the Initial CD8(+) T Cell Response against HIV-1. PLoS Med 3 e403

50. PriceD

GoulderP

KlenermanP

SewellA

EasterbrookP

1997 Positive selection of HIV-1 cytotoxic T lymphocyte escape variants during primary infection. Proc Natl Acad Sci U S A 94 1890 1895

51. YangOO

SarkisPT

AliA

HarlowJD

BranderC

2003 Determinant of HIV-1 mutational escape from cytotoxic T lymphocytes. J Exp Med 197 1365 1375

52. Lubong SabadoR

KavanaghD

KaufmannD

FruK

BabcockE

2009 In vitro priming recapitulates in vivo HIV-1 specific T cell responses, revealing rapid loss of virus reactive CD4 T cells in acute HIV-1 infection. PLoS One 4 e4256

53. StreeckH

JolinJ

QiY

Yassine-DiabB

JohnsonR

2009 HIV-1-specific CD8+ T cell responses during primary infection are major determinants of the viral set point and loss of CD4+ T cells. J Virol 83 15 7641 8

54. KloetzelPM

2001 Antigen processing by the proteasome. Nat Rev Mol Cell Biol 2 179 187

55. KloetzelPM

OssendorpF

2004 Proteasome and peptidase function in MHC-class-I-mediated antigen presentation. Curr Opin Immunol 16 76 81

56. YewdellJ

2005 Immunoproteasomes: regulating the regulator. Proc Natl Acad Sci U S A 102 9089 9090

57. KisselevA

AkopianT

WooK

GoldbergA

1999 The sizes of peptides generated from protein by mammalian 26 and 20 S proteasomes. Implications for understanding the degradative mechanism and antigen presentation. J Biol Chem 274 3363 3371

58. CascioP

HiltonC

KisselevA

RockK

GoldbergA

2001 26S proteasomes and immunoproteasomes produce mainly N-extended versions of an antigenic peptide. EMBO J 20 2357 2366

59. SaminoY

LópezD

GuilS

SaveanuL

van EndertP

2006 A long N-terminal-extended nested set of abundant and antigenic major histocompatibility complex class I natural ligands from HIV envelope protein. J Biol Chem 281 6358 6365

60. ReitsE

GriekspoorA

NeijssenJ

GroothuisT

JalinkK

2003 Peptide diffusion, protection, and degradation in nuclear and cytoplasmic compartments before antigen presentation by MHC class I. Immunity 18 97 108

61. ChoppinJ

CohenW

BiancoA

BriandJ

ConnanF

2001 Characteristics of HIV-1 Nef regions containing multiple CD8+ T cell epitopes: wealth of HLA-binding motifs and sensitivity to proteasome degradation. J Immunol 166 6164 6169

62. DongT

Stewart-JonesG

ChenN

EasterbrookP

XuX

2004 HIV-specific cytotoxic T cells from long-term survivors select a unique T cell receptor. J Exp Med 200 1547 1557

63. DongT

Stewart-JonesG

ChenN

EasterbrookP

XuX

2004 HIV-specific cytotoxic T cells from long-term survivors select a unique T cell receptor. J Exp Med 200 1547 1557